We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-16.54%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$160M
AUM Growth
–
Cap. Flow
+$170M
Cap. Flow %
106.48%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALLO icon
Allogene Therapeutics
ALLO
+$67.8M
2
DYN icon
Dyne Therapeutics
DYN
+$65M
3
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$18.2M
4
QTTB icon
Q32 Bio
QTTB
+$9.6M
5
ASMB icon
Assembly Biosciences
ASMB
+$9.44M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$604M
$67.8M 42.47%
+1,798,163
New +$67.8M
DYN icon
2
Dyne Therapeutics
DYN
$4.24B
$59.8M 37.43%
+2,960,046
New +$65M
OYST
3
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$16.4M 10.29%
+778,468
New +$18.2M
QTTB icon
4
Q32 Bio
QTTB
$452M
$8.25M 5.17%
+42,825
New +$9.6M
ASMB icon
5
Assembly Biosciences
ASMB
$513M
$7.4M 4.63%
+37,500
New +$9.44M

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q3 2020 Portfolio in Review

Q3 2020 is the first quarter with a 13F filing on record for Vida Ventures Advisors, which disclosed 5 positions worth $160M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Allogene Therapeutics: 1,798,163 shares worth $67.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Vida Ventures Advisors's largest Q3 2020 buy was Allogene Therapeutics: 1,798,163 shares worth $67.8M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $160M portfolio in Q3 2020.
  • Vida Ventures Advisors disclosed 5 positions in Q3 2020, its first 13F filing on record.

Based on Vida Ventures Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.